An inducible Tet-Off-H2B-GFP lentiviral reporter vector for detection and in vivo isolation of label-retaining cells

Experimental Cell Research

Volumn 316, Issue 11, 2010, Pages 1885-1895

  Falkowska Hansen, Berit ^a   Kollar, Jasmin ^a   Grüner, Barbara Maria ^b   Schanz, Merle ^c   Boukamp, Petra ^a   Siveke, Jens ^b   Rethwilm, Axel ^c   Kirschner, Marc ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

H2B GFP; Isolation of LRCs; Label retaining cells; Lentiviral; Tet Off

Indexed keywords

DOXYCYCLINE; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MITOMYCIN C; REGULATOR PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTODIAGNOSIS; DRUG STABILITY; EX VIVO STUDY; GENE CONSTRUCT; GENETIC ENGINEERING; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PANCREAS CELL; PRIORITY JOURNAL; RELIABILITY; REPORTER GENE; SKIN CELL; TISSUE CULTURE; TRANSGENICS; VIRUS DETECTION;

EID: 77953232124     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.02.015     Document Type: Article

References (41)

1. Bickenbach J.R., Mackenzie I.C. Identification and localization of label-retaining cells in hamster epithelia. J. Invest. Dermatol. 1984, 82:618-622.
2. Morris R.J., Fischer S.M., Slaga T.J. Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen. Cancer Res. 1986, 46:3061-3066.
3. Bickenbach J.R. Identification and behavior of label-retaining cells in oral mucosa and skin. J. Dent. Res. 1981, 60:1611-1620. Spec No C.
4. Bickenbach J.R., McCutecheon J., Mackenzie I.C. Rate of loss of tritiated thymidine label in basal cells in mouse epithelial tissues. Cell Tissue Kinet. 1986, 19:325-333.
5. Potten C.S. The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinet. 1974, 7:77-88.
6. Cotsarelis G., Sun T.-T., Lavker R.M. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990, 61:1329-1337.
7. Muffler S., Stark H.J., Amoros M., Falkowska-Hansen B., Boehnke K., Buhring H.J., Marme A., Bickenbach J.R., Boukamp P. A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures. Stem Cells 2008, 26:2506-2515.
8. Tumbar T., Guasch G., Greco V., Blanpain C., Lowry W.E., Rendl M., Fuchs E. Defining the epithelial stem cell niche in skin. Science 2004, 303:359-363.
9. Kanda T., Sullivan K.F., Wahl G.M. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 1998, 8:377-385.
10. Diamond I., Owolabi T., Marco M., Lam C., Glick A. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J. Invest. Dermatol. 2000, 115:788-794.
11. Boukamp P., Stanbridge E.J., Foo D.Y., Cerutti P.A., Fusenig N.E. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res. 1990, 50:2840-2847.
12. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106:761-771.
13. Kirschner M., Monrose V., Paluch M., Techodamrongsin N., Rethwilm A., Moore J.P. The production of cleaved, trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent. Protein Expr. Purif. 2006, 48:61-68.
14. Limon A., Briones J., Puig T., Carmona M., Fornas O., Cancelas J.A., Nadal M., Garcia J., Rueda F., Barquinero J. High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood 1997, 90:3316-3321.
15. Boehnke K., Mirancea N., Pavesio A., Fusenig N.E., Boukamp P., Stark H.J. Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents. Eur. J. Cell Biol. 2007, 86:731-746.
16. Siveke J.T., Einwachter H., Sipos B., Lubeseder-Martellato C., Kloppel G., Schmid R.M. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 2007, 12:266-279.
17. Denham M., Huynh T., Dottori M., Allen G., Trounson A., Mollard R. Neural stem cells express non-neural markers during embryoid body coculture. Stem Cells 2006, 24:918-927.
18. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
19. Nieto A., Cabrera C.M., Catalina P., Cobo F., Barnie A., Cortés J.L., Barroso del Jesus A., Montes R., Concha A. Effect of mitomycin-C on human foreskin fibroblasts used as feeders in human embryonic stem cells: immunocytochemistry MIB1 score and DNA ploidy and apoptosis evaluated by flow cytometry. Cell Biol. Int. 2007, 31:269-278.
20. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5547-5551.
21. Challen G.A., Goodell M.A. Promiscuous expression of H2B-GFP transgene in hematopoietic stem cells. PLoS One 2008, 3:e2357.
22. Brennand K., Huangfu D., Melton D. All beta cells contribute equally to islet growth and maintenance. PLoS Biol. 2007, 5:e163.
23. Kafri T., van Praag H., Gage F.H., Verma I.M. Lentiviral vectors: regulated gene expression. Mol. Ther. 2000, 1:516-521.
24. Urlinger S., Baron U., Thellmann M., Hasan M.T., Bujard H., Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7963-7968.
25. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol. 2003, 21:117-122.
26. Vigna E., Cavalieri S., Ailles L., Geuna M., Loew R., Bujard H., Naldini L. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Ther. 2002, 5:252-261.
27. Frecha C., Szecsi J., Cosset F.L., Verhoeyen E. Strategies for targeting lentiviral vectors. Curr. Gene. Ther. 2008, 8:449-460.
28. Foudi A., Hochedlinger K., Van Buren D., Schindler J.W., Jaenisch R., Carey V., Hock H. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat. Biotech. 2009, 27:84-90.
29. Wilson A., Laurenti E., Oser G., van der Wath R.C., Blanco-Bose W., Jaworski M., Offner S., Dunant C.F., Eshkind L., Bockamp E., Lio P., Macdonald H.R., Trumpp A. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118-1129.
30. Schambach A., Baum C. Clinical application of lentiviral vectors-concepts and practice. Curr. Gene Ther. 2008, 8:474-482.
31. Cockrell A.S., Kafri T. Gene delivery by lentivirus vectors. Mol. Biotechnol. 2007, 36:184-204.
32. Bhagwandin V.J., Shay J.W. Pancreatic cancer stem cells: fact or fiction?. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2009, 1792:248-259.
33. Yang Y.M., Chang J.W. Current status and issues in cancer stem cell study. Cancer Invest. 2008, 26:741-755.
34. Schatton T., Frank M.H. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res. 2008, 21:39-55.
35. Tang C., Ang B.T., Pervaiz S. Cancer stem cell: target for anti-cancer therapy. FASEB J. 2007, 21:3777-3785.
36. Zabierowski S.E., Herlyn M. Melanoma stem cells: the dark seed of melanoma. J. Clin. Oncol. 2008, 26:2890-2894.
37. Cornils K., Lange C., Schambach A., Brugman M.H., Nowak R., Lioznov M., Baum C., Fehse B. Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance. Mol. Ther. 2009, 17:131-143.
38. Thornhill S.I., Schambach A., Howe S.J., Ulaganathan M., Grassman E., Williams D., Schiedlmeier B., Sebire N.J., Gaspar H.B., Kinnon C., Baum C., Thrasher A.J. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol. Ther. 2008, 16:590-598.
39. Zychlinski D., Schambach A., Modlich U., Maetzig T., Meyer J., Grassman E., Mishra A., Baum C. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol. Ther. 2008, 16:718-725.
40. Day C.P., Carter J., Bonomi C., Esposito D., Crise B., Ortiz-Conde B., Hollingshead M., Merlino G. Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study. Pigment Cell Melanoma Res. 2009, 22:283-295.
41. Modlich U., Navarro S., Zychlinski D., Maetzig T., Knoess S., Brugman M.H., Schambach A., Charrier S., Galy A., Thrasher A.J., Bueren J., Baum C. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol. Ther. 2009, 17:1919-1928.